PROGNOSTIC AND PREDICTIVE GENE SIGNATURE FOR NON-SMALL CELL LUNG CANCER AND ADJUVANT CHEMOTHERAPY

Patent №

US 8,211,643

Granted

2012-07-03

Filed 2009

Owner

UNIVERSITY HEALTH NETWORK

Lab

AI components

2

ml · evo

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

12465954

The application provides methods of prognosing and classifying lung cancer patients into poor survival groups or good survival groups and for determining the benefit of adjuvant chemotherapy by way of a multigene signature. The application also includes kits and computer products for use in the methods of the application.

Machine learningEvolutionary computationC12Q 1/6886G01N 33/5752G16B 25/00G16B 25/10G16B 40/00G16B 40/30G16H 50/30C12Q 2600/106+4 more

AI classification

Evolutionary computation0.93
Machine learning0.60
Knowledge representation0.03
Natural language0.01
Vision0.00
Planning0.00
AI hardware0.00
Speech0.00

Ownership

UNIVERSITY HEALTH NETWORK

assignment · 231450549

Assignors

TSAO, MING-SOUND, SHEPHERD, FRANCES A., JURISICA, IGOR, DER, SANDY D., STRUMPF, DAN, ZHU, CHANG-QI, SEYMOUR, LESLEY, DING, KEYUE

On an employer assignment, the assignors are typically the inventors.

From the same owner

© 2026 NYSGPT2525 LLC